PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer

Prostate Cancer and Prostatic Diseases, Published online: 05 May 2023; doi:10.1038/s41391-023-00666-2PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer

Source: Prostate Cancer and Prostatic Diseases - May 5, 2023 Category: Urology & Nephrology Authors: Tahlia Scheinberg Hui-Ming Lin Michael Fitzpatrick Arun A. Azad Paul Bonnitcha Amy Davies Gillian Heller Kevin Huynh Blossom Mak Kate Mahon David Sullivan Peter J. Meikle Lisa G. Horvath Source Type: research